IGF-II level is found elevated in breast cancer patients and its involvement in cancer development could be seen through the MAPK pathway where IGF signal activates genes concerned with cell proliferation; and reduce the apoptosis event via the PI3-K/Akt pathway, hence, the occurrence of tumorigenesis [30]. The gene discussed is IGF1; the disease is breast cancer.